Under-30s in the UK are to be offered an alternative Covid vaccine to the AstraZeneca jab due to the evidence linking it to rare blood clots.
The recommendation comes after a review by the UK drugs regulator found that by the end of March 79 people had suffered rare blood clots after vaccination – 19 of whom had died.
The regulator said this was not proof the jab had caused the clots.
But it said the link was getting firmer.
The review by the Medicines and Healthcare products Regulatory Agency (MHRA) found:
- The 79 cases and 19 deaths occurred after 20 million doses were administered – giving a risk of about four in one million of developing a blood clot, and one in a million of dying
- Nearly two-thirds of the cases of rare clots were seen in women
- The people who died were aged between 18 and 79, with three of them aged under 30
- All the recorded cases occurred after the first dose, although the lower number of second doses meant it was not possible to draw any conclusions from this
Meanwhile, the EU’s medicines regulator says unusual blood clots should be listed as a possible very rare side effect of the AstraZeneca jab, but that the benefits outweighed the risks. Some European countries have restricted the vaccine’s use.
The World Health Organization said the link between the vaccine and blood clots was “plausible” but not confirmed, adding that the clotting incidents were “very rare” among nearly 200 million people who have received the jab worldwide.
Kenya received over a million does of the AstraZeneca vaccine through the COVAX initiative. Most of it have laid in warehouses a the slow vaccination progress takes place.
Kenyans doesn’t trust their government and most saw this as a plan to look for ways to import vaccine through private firms so as profit from it.
“It is quite unfortunate that the government banned Sputnik V vaccine that had become trusted by the masses who feared AstraZeneca jab due to issues of blood clots”, a person familiar with the matter told Kenyan Business Feed.
The Law Society of Kenya moved to court to have it declare the ban illegal.
In the case that he wants certified urgent, Mr Hav, LSK President, says the ban and cancellation of licences issued to importers and distributors of the vaccine should not have been made when the government has set its vaccination goal by January 2022 at 30 per cent of the population.
In a free market economy, the private and govt entities can exist side by side. Some Kenyans have their doubts about AstraZeneca vaccine and they must be acorded an alternative.
Kenyan Business Feed is the top Kenyan Business Blog. We share news from Kenya and across the region. To contact us with any alert, please email us to edit[email protected]